scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1002/(SICI)1521-1878(199801)20:1<79::AID-BIES11>3.3.CO;2-I |
P8608 | Fatcat ID | release_nbt4qtz7bjgmxpdbshtjqolx24 |
P698 | PubMed publication ID | 9504050 |
P2093 | author name string | Evans RM | |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 79-86 | |
P577 | publication date | 1998-01-01 | |
P1433 | published in | BioEssays | Q4914614 |
P1476 | title | Vimentin: the conundrum of the intermediate filament gene family | |
P478 | volume | 20 |
Q40300855 | A genetic strategy to overcome the senescence of primary meningioma cell cultures |
Q38285932 | A novel role of vimentin filaments: binding and stabilization of collagen mRNAs |
Q36049841 | Ablation of vimentin results in defective steroidogenesis |
Q64890703 | An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry. |
Q40081963 | Bovine caruncular epithelial cell line (BCEC-1) isolated from the placenta forms a functional epithelial barrier in a polarised cell culture model |
Q35918764 | Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation |
Q30984590 | Confocal microscopic evidence of decreased alpha-actin expression within rabbit cerebral artery smooth muscle cells after subarachnoid haemorrhage |
Q36218232 | Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells |
Q37437672 | Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma |
Q37564586 | Downregulation of vimentin expression increased drug resistance in ovarian cancer cells |
Q75322267 | Expression of intermediate filaments of podocytes within nephrotic syndrome glomerulopathies in children |
Q37255246 | Fibroblast-myocyte coupling in the heart: Potential relevance for therapeutic interventions |
Q90643405 | Filaments and phenotypes: cellular roles and orphan effects associated with mutations in cytoplasmic intermediate filament proteins |
Q36944507 | Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. |
Q39810943 | Identification of a novel vimentin promoter and mRNA isoform |
Q27321346 | Lipid droplets, perilipins and cytokeratins--unravelled liaisons in epithelium-derived cells |
Q90101124 | Low-Level Laser Therapy Prevents Treadmill Exercise-Induced Progression of Arthrogenic Joint Contracture Via Attenuation of Inflammation and Fibrosis in Remobilized Rat Knees |
Q36518963 | Murine colitis is mediated by vimentin |
Q37734270 | Myocardial fibroblast-matrix interactions and potential therapeutic targets |
Q26827684 | RNA protein interactions governing expression of the most abundant protein in human body, type I collagen |
Q34829230 | Role of the cytoskeleton in formation and maintenance of angiogenic sprouts |
Q33943560 | Taste cell function. Structural and biochemical implications |
Q46370066 | The cytoskeleton meets the skeleton. Focus on "Deficiency of the intermediate filament synemin reduces bone mass in vivo". |
Q37527096 | The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature |
Q34389714 | The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis |
Q58702541 | Vimentin Diversity in Health and Disease |
Q35182104 | Vimentin in cancer and its potential as a molecular target for cancer therapy |
Q34168677 | Viral nanoparticles as platforms for next-generation therapeutics and imaging devices |